Entries by Citron Research

Benefytt Technologies – A Leader in Offering Telemedicine Benefits to Seniors… Says the Secretary of Health and Human Services

Price Target $60 Yesterday’s White House briefing to the country on the COVID-19 pandemic started and ended with the same theme – the need for more telemedicine offerings for seniors.  This is not a trend or a fad… this is the moment that will make telemedicine mainstream and Benefytt Technologies is at the forefront of […]

,

Citron Updates Schrodinger ($SDGR)

  2020 Target Price – $80 Last week, Citron Research issued an opinion on $SDGR calling it the most important IPO of the last 5 years.  We purposely did not use the words “Corona Virus” in the report in order to eschew from the report being considered opportunist or promotional.  But the obvious has to […]

LOPE – The Educational Enron

The Multiple Smoking Guns that Prove LOPE is Using a Captive Subsidiary to Manipulate Earnings. Citron Research is entering our 19th year of publishing independent research.  In our 19 years, we have exposed more corporate fraud than any non-government agency across the globe.  With that in mind, we are judicious when we use the “F” […]

FleetCor – Citron believes FTC Lawsuit is Imminent

“Let me be clear.  My bet would be that FleetCor is subject to an FTC order either through consent or litigation where FleetCor must pay a significant amount of money and be subject to a consent decree that alters the company’s billing and marketing practices.” – Former Director of the FTC’s Bureau of Consumer Protection […]